Six beagle dogs were treated with kanamycin subcutaneously or intravenously
in a dosage of 5 mg/kg. The plasma kanamycin concentration was measured ov
er 24 hours by high pressure liquid chromatography with UV detection after
derivatization and solid phase extraction. After subcutaneous application,
kanamycin was absorbed quickly, and maximum plasma levels of 18.9 mug/ml in
average after ca. 1 hour were measured. With complete systemic availabilit
y, the minimal inhibitory concentration of 4 mug/ml was maintained for 4 ho
urs. After subcutaneous administration, kanamycin was terminally eliminated
with a mean half life period of 2 hours.